Cytoplasmic membrane variation of <i>E. coli</i> UB1005 treated by peptide and ME26. Wei Xu Xin Zhu Tingting Tan Weizhong Li Anshan Shan 10.1371/journal.pone.0098935.g008 https://plos.figshare.com/articles/figure/_Cytoplasmic_membrane_variation_of_E_coli_UB1005_treated_by_peptide_and_ME26_/1062611 <p>The dye (diSC<sub>3</sub>-5) release intensity was monitored at an excitation wavelength of 622 nm and an emission wavelength of 670 nm. The concentrations of the peptides were their 2× MIC (A, R-FV-I16; B, ME26), and 1× MIC (C, R-FV-I16; D, ME26).</p> 2014-06-19 03:19:26 Clinical medicine pharmacology Drug research and development drug discovery membrane ub1005 treated peptide